BVS
NASDAQ
US
Bioventus Inc. - Class A Common Stock
$8.97
▼ $-0.18
(-1.97%)
Vol 318K
9
Quality Score
ok
Deep Check
1/5
fail
Rev ✓
NI ✗
>IPO ✗
Mkt Cap
$615.8M
P/E
78.7
ROE
5.0%
Margin
1.4%
D/E
200.14
Beta
0.83
52W
$6–$11
Wall Street Consensus
9 analysts · Apr 20262
Strong Buy
6
Buy
1
Hold
0
Sell
0
Strong Sell
88.9%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 75.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $0.22 | $0.24 | +$0.02 |
| Sep 2025 | $0.12 | $0.15 | +$0.03 |
| Jun 2025 | $0.21 | $0.21 | $0.00 |
| Mar 2025 | $0.02 | $0.08 | +$0.06 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | $153.6M | $123.9M | $147.7M | $138.7M | $157.9M |
| Net Income | — | -$156K | -$2.6M | $7.5M | $3.2M | $14.8M |
Fundamentals Trend
| Metric | 2025-06-28 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -0.1% | -0.1% | -0.1% | -0.1% | 5.0% | 5.0% |
| P/E (TTM) | — | — | — | — | 80.00 | 78.73 |
| Net Margin | 5.1% | -0.0% | -0.0% | -0.0% | 1.4% | 1.4% |
| Gross Margin | 69.1% | 67.6% | 67.6% | 67.6% | 67.8% | 67.8% |
| D/E Ratio | 217.86 | 217.86 | 217.86 | 217.86 | 200.14 | 200.14 |
| Current Ratio | 1.48 | 1.48 | 1.48 | 1.48 | 1.74 | 1.74 |
Key Ratios
ROA (TTM)
1.1%
P/S (TTM)
1.09
P/B
5.8
EPS (TTM)
$0.11
CF/Share
$-1.35
Rev Growth 3Y
+10.0%
52W High
$11.25
52W Low
$5.81
$5.81
52-Week Range
$11.25
Financial Health
Free Cash Flow
$37.4M
Net Debt
$242.7M
Cash
$51.2M
Total Debt
$294.0M
As of Dec 31, 2025
How does BVS compare to Health Care peers?
Peer group: Micro-cap Health Care (All) · 241 companies
BVS valuation vs Health Care peers
P/E ratio
78.7
▲
156%
above
peers
(30.7)
vs Peers
vs Industry
Undervalued
P/S ratio
1.1
▼
58%
below
peers
(2.6)
vs Peers
vs Industry
Undervalued
P/B ratio
5.8
▲
107%
above
peers
(2.8)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.7%)
vs Peers
vs Industry
Low yield
BVS profitability vs Health Care peers
ROE
5.0%
▲
113%
above
peers
(-38.5%)
vs Peers
vs Industry
Top tier
Net margin
1.4%
▲
106%
above
peers
(-24.7%)
vs Peers
vs Industry
Top tier
Gross margin
67.8%
▲
28%
above
peers
(52.9%)
vs Peers
vs Industry
Below avg
ROA
1.1%
▲
105%
above
peers
(-21.2%)
vs Peers
vs Industry
Top tier
BVS financial health vs Health Care peers
D/E ratio
200.1
▲
938%
above
peers
(19.3)
vs Peers
vs Industry
High debt
Current ratio
1.7
▼
20%
below
peers
(2.2)
vs Peers
vs Industry
Low liquidity
Beta
0.8
▼
21%
below
peers
(1.1)
vs Peers
vs Industry
More volatile
BVS fundamentals radar
BVS
Peer median
Industry
BVS profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
BVS vs peers: key metrics
Latest News
No related news yet